Search

Pyrazoline and pyrazole compounds are important building blocks in the development of photofunctional compounds. Two new solution-processable platinum-containing polyynes functionalized with these chromophores in the main chain (P1 and P2) were synthesized and characterized by spectroscopic, thermal and optical methods. By changing the spacer from 2-pyrazoline to the electron-rich pyrazole in the main chain, the photophysical properties including energy levels, absorption wavelength and bandgap of the polymers were finely tuned. The photovoltaic properties of P1 with better absorption features were also studied. [ABSTRACT FROM AUTHOR]

The main building blocks for the production of flavonoids and iso-flavonoids are chalcones. Chalcones are α, β-unsaturated carbonyl compounds containing three carbons. The condensation products of aromatic aldehydes with acetophenones in the presence of a catalyst are called chalcones. Numerous techniques and plans have been documented for the synthesis of these substances. Aldol condensation and Claisen–Schmidt condensation continue to hold a prominent position among all. Chalcones and their derivatives have a broad range of pharmacological activities due to presence of reactive α,β-unsaturated carbonyl group. Numerous chalcone-heterocycle hybrids seem to show promise as potential medication candidates based on a review of the literature because of their comparable or better activity than the standards. As a result, the creation and development of novel, highly effective therapeutic medications based on previously established techniques may benefit from this review. [ABSTRACT FROM AUTHOR]

The synthesis of 2-(benzo[d]thiazol-2-yl)-N-arylacetamide derivatives was achieved by cyclocondensation reaction of 2-aminothiophenol and different cyanoacetamide derivatives in solvent free condition and without any catalyst. The resultant products were used as a precursor for synthesis novel acetamide, acrylamide, pyrazole and pyridine derivatives via reaction with different reagents. All reaction products have been tested for their antioxidant activities compared with ascorbic acid. Some on novel synthesized products furnished promising results. [ABSTRACT FROM AUTHOR]

A method for targeted structural modification of the methyl ester of phlomisoic acid was developed by introduction of an additional C-16 ketopyrazole moiety via cyclocondensation of diterpenoid alkyne-1,2- diones with arylhydrazines. The conditions for regioselective formation of labdanoid 1,3-diarylpyrazol-5- ylmethanones were found. The possibility of a sequential four-component reaction in a single pot was demonstrated. Significant analgesic activity of labdanoid-substituted diarylpyrazoles in thermal and chemical irritation models was established. [ABSTRACT FROM AUTHOR]

This report detailed the synthesis of multi‐substituted pyrazoles through the acceptorless dehydrogenative coupling (ADC) reaction catalyzed by a well‐defined manganese(I)‐pincer complex. Symmetrically substituted pyrazoles were synthesized by reacting 1,3‐diols with hydrazines. Unsymmetrically substituted pyrazoles were selectively made via the ADC of primary alcohols with methyl hydrazones. Water and hydrogen are liberated as the green byproducts. The endurance of these methodologies has been presented by producing 30 substrates with varied functionalities. Model reactions were scaled up to demonstrate practicability. The reaction rate and order were measured to transparent the involvement of the reagents during catalysis. Control experiments elucidated the plausible reaction mechanisms. [ABSTRACT FROM AUTHOR]

We have developed a straightforward electrochemical protocol for direct α-amidation and α-pyrazolation of N-alkoxy- and N-aryloxycarbonyl pyrrolidines with amides or pyrazoles. Unlike previously reported methods, this protocol does not require pre-prepared amidation reagents, thereby shortening the synthesis route and boosting atom economy. Various functional groups are tolerated, and the reaction proceeds at room temperature in only 2.5 h without assistance from chemical oxidants or catalysts. [ABSTRACT FROM AUTHOR]

Regioselective C6‐arylation of thieno[3,2‐c]pyrazoles with aryl iodides as coupling partners has been developed. This strategy was performed in the presence of Pd(OAc)2 as catalyst in combination with AgOTf as an oxidant and TFA in dimethylacetamide. In all experiments, only the C6‐arylated thieno[3,2‐c]pyrazole was isolated since its C5‐regioisomer was not observed, indicating the high regioselectivity of this approach. The catalytic system used is compatible with a variety of 3‐functionalized thieno[3,2‐c]pyrazoles and iodoaryl electrophiles, providing access to 3,6‐disubstituted thieno[3,2‐c]pyrazoles in yields ranging from 49% to 94%. [ABSTRACT FROM AUTHOR]

The catalytic asymmetric reaction of 5‐aminopyrazoles with naphthoquinone esters has been established. A wide range of unprecedented axially chiral naphthylpyrazole derivatives (29 examples) have been synthesized in moderate to excellent yields (up to 99 % yield) with excellent enantioselectivities (up to 99 % ee) by utilizing chiral phosphoric acid as a catalyst. This protocol features mild reaction conditions, a broad substrate scope, good scalability and facile derivatization. Moreover, preliminary mechanistic investigation was conducted to elucidate the mechanism. [ABSTRACT FROM AUTHOR]

A series of 4-hydroxy-6-methyl-3-(1-(4-(aryl/methyl)thiazol-2-yl)-1H-pyrazol-3-yl)-2H-pyran-2-ones 3a–h have been synthesized from aryl/methyl halomethylketones and a key pyrazole intermediate 1 using a convenient one-pot synthesis method. All compounds were characterized by NMR and MS, and the structure of three of them (3a, 3b and 3f) was resolved by X-ray diffraction. These heteroatom-rich thiazole compounds were then evaluated as inhibitors of Mycobacterium tuberculosis InhA, a key enzyme involved in the type II fatty acid biosynthesis pathway of the mycobacterium. Although inhibitory activities were found to be rather weak, molecular docking studies were also been carried out to understand a possible mode of interaction with key residues in the enzyme's active site. [ABSTRACT FROM AUTHOR]

In this research, with an aim to develop novel pyrazole oxime ether derivatives possessing potential biological activity, thirty-two pyrazole oxime ethers, including a substituted pyridine ring, have been synthesized and structurally identified through 1H NMR, 13C NMR, and HRMS. Bioassay data indicated that most of these compounds owned strong insecticidal properties against Mythimna separata, Tetranychus cinnabarinus, Plutella xylostella, and Aphis medicaginis at a dosage of 500 μg/mL, and some title compounds were active towards Nilaparvata lugens at 500 μg/mL. Furthermore, some of the designed compounds had potent insecticidal effects against M. separata, T. cinnabarinus, or A. medicaginis at 100 μg/mL, with the mortalities of compounds 8a, 8c, 8d, 8e, 8f, 8g, 8o, 8s, 8v, 8x, and 8z against A. medicaginis, in particular, all reaching 100%. Even when the dosage was lowered to 20 μg/mL, compound 8s also expressed 50% insecticidal activity against M. separata, and compounds 8a, 8e, 8f, 8o, 8v, and 8x displayed more than 60% inhibition rates against A. medicaginis. The current results provided a significant basis for the rational design of biologically active pyrazole oxime ethers in future. [ABSTRACT FROM AUTHOR]

Metal-mediated inner-sphere N–N coupling is an uncommon route to N–N bond formation. Herein, we report a mechanistic study of pyrazole formation via oxidation-induced N–N coupling of diazatitanacycles. In TEMPO oxidation reactions, the first of two oxidations is rate limiting and TEMPO coordination to Ti is critical for reactivity. In oxidations with Fc+ salts, coordinating counteranions such (eg. Cl−) aid an "inner-sphere-like" oxidation. [ABSTRACT FROM AUTHOR]

We here reported a highly stereoselective method for the synthesis of polysubstituted conjugated dienes from α‐aryl α‐diazo alkynyl ketones and pyrazole‐substituted unsymmetric aminals under mild conditions, which was promoted by photo‐irridation and involved with 1,6‐dipolar intermediate and quadruple sigmatropic rearrangements, was successfully developed. In this transformation, the cleavage of four bonds and the recombination of five bonds were implemented in one operational step. This protocol provided a modular tool for constructing dienes from amines, pyrazoles and α‐alkynyl‐α‐diazoketones in one‐pot manner. The results of mechanistic investigation indicated that the plausible reaction path underwent the 1,6‐sigmatropic rearrangement instead of the 1,5‐sigmatropic rearrangement. [ABSTRACT FROM AUTHOR]

A straightforward protocol has been developed to access 3-selenylated pyrazolo[1,5-a]pyrimidines from readily available amino pyrazoles, chalcones, and diaryl/dialkyl diselenides. This I2-catalyzed methodology is highly useful for synthesizing a wide range of functionalized 3-(aryl/alkylselanyl)pyrazolo[1,5-a]pyrimidine derivatives. Mechanistic investigation disclosed that iodine catalysis is very important in both the cyclization process as well as in the C-H selenylation step. Moreover, the developed reaction conditions are also applicable for the cyclization of amino pyrazole with enaminone followed by C-H selenylation in one pot. The use of simple reagents and catalyst, wide substrate scope, mild and metal-free reaction conditions, and practical applicability are the attractive facets of this approach. [ABSTRACT FROM AUTHOR]

In this work, the unique performance of binary acid‐base CuO/La2O3 nanocomposite as a highly efficient heterogeneous catalyst was successfully examined for the one‐pot multicomponent synthesis of pyrano [2, 3‐c] pyrazole derivatives. The strong interactions between La and Cu had a profound effect on the catalytic activity of nanocatalysts. In addition, high selectivity, easy recovery, reusability, a very reasonable price, simple preparation and eco‐friendliness are other important advantages of this nanocatalyst. The characterized nanocomposite demonstrated excellent structural and morphological properties, leading to high catalytic efficiency. Characterization using Fourier Transform Infrared Spectroscopy (FT‐IR), X‐ray Powder Diffraction (XRD) confirmed crystallographic structure, and Field Emission Scanning Electron Microscopy (FE‐SEM) showed a spherical particle size of approximately 43 nm. Energy‐Dispersive X‐ray (EDX) analysis confirmed the composition of La, O, and Cu elements in the nanocomposite as 86.4 %, 13.5 %, and 0.2 %, respectively. The optimal condition for the synthesis resulted in a 98 % yield of pyrano [2, 3‐c] pyrazole derivatives under reflux with 0.02 g of CuO/La2O3 catalyst in a 10‐minute reaction time. [ABSTRACT FROM AUTHOR]

This article discusses a catalytic strategy for the conversion of isoxazoles and oxadiazoles into pyrazoles and 1,2,4-triazoles, respectively, through a formal O-to-N exchange. The protocol utilizes catalytic amounts of an air-stable Ni(4-CF3 stb) 3 complex in combination with hydrazine. The authors demonstrate the generality of the protocol and its functional group tolerance. This research provides a potential solution for the rapid evaluation of five-membered heterocyclic scaffolds in synthetic campaigns. [Extracted from the article]

New C–N-bonded bisazoles were obtained by cine-substitution of 1,3-dinitro-1H-pyrazole-4-carbonitrile by the action of N-azoles. Their spectral characteristics were investigated using multinuclear NMR spectroscopy. [ABSTRACT FROM AUTHOR]

A fully continuous-flow nitration and post-processing protocol has been introduced into the preparation of 4-nitropyrazole. The process started from the nitration reaction of pyrazole with mixed acid, followed by continuous quenching, neutralization, extraction and separation. After the collected organic phase was rotationally evaporated to recover the solvent, the final product 4-nitropyrazole was obtained with 96.9% yield, 99.3% purity and 381 g/h productivity. By establishing a kinetics model and MATLAB simulation calculation, it worked out to achieve the preferable selectivity conditions of mono-nitration product 4-nitropyrazole. The process of post-processing solved the problems of solid precipitation and extractant hydrolysis. The extraction process was determined by the distribution coefficient and twice extraction was used to reduce the amount of organic solvent. [ABSTRACT FROM AUTHOR]

Extending the family of oxothiomolybdates, the interaction of the cyclic anion [Mo8O8S8(OH)8(C2O4)]2− and the complex [Mo4O4S4(C2O4)5]6− with organic compounds of the azole series—pyrazole (pzH) and 1,2,4-triazole (trzH) in water solution and in the melt of ligands was investigated. In water solution pyrazole plays only the role of cation (upon protonation) to form the complex (pzH2)2[Mo2O2S2(C2O4)2(H2O)2]. While in the reaction in melt of pzH in the case of the initial cyclic anion, the resulting anionic product [Mo6O6S6(pz)6(MoO4)]2− represents a pioneering example of a cyclic oxothiometalate {Mo6} anchored by the coordination of six bridging pyrazolates (pz), complemented by a MoO42− core. At the same time, the interaction of [Mo4O4S4(C2O4)5]6− with pzH and trzH melts yields the binuclear clusters [Mo2O2S2(C2O4)2L2]2−, where L = pzH or trzH. The composition and structures of the compounds were determined using a variety of physicochemical methods, including single-crystal X-ray diffraction analysis. [ABSTRACT FROM AUTHOR]

Background: Pyrazole derivatives have gained attention as potential leads for developing anti-inflammatory and analgesic drugs. Chemical modifications of pyrazole structures offer a strategy to enhance their therapeutic properties, while minimizing undesirable effects. Objective: This study aimed to synthesize novel pyrazole derivatives through chemical modifications and assess their anti-inflammatory and analgesic activities. Methods: A series of pyrazole variants were synthesized by reacting various acetophenone derivatives and diethyl oxalate in basic conditions, followed by treatment with glacial acetic acid and hydrazine hydrate. The resulting compounds were further methylated and acetylated. The synthesized compounds were characterized using elemental analysis, 1H NMR, IR, and MASS spectroscopy. The anti-inflammatory activity was evaluated using the rat paw edema technique induced by carrageenan, while the analgesic activity was assessed using the writhing reflux method. Results: Among the newly synthesized pyrazole derivatives, compounds 3b, 3e and 3g′ demonstrated significant anti- inflammatory activity with reduced ulcerogenic potential. Compounds 3d,3b′ and 3d′ exhibited notable analgesic activity compared to the standard drug. The chemical modifications introduced in these derivatives were confirmed through spectroscopic analyses. Conclusion: The findings of this study highlight the potential of pyrazole derivatives as promising candidates for anti- inflammatory and analgesic drug development. The structural modifications performed in this research improved the therapeutic activities of the compounds, while addressing safety concerns. Further investigations are warranted to elucidate the underlying mechanisms of action and optimize the pharmacological profiles of these novel pyrazole derivatives. This study synthesized novel pyrazole derivatives and evaluated their anti-inflammatory and analgesic properties. Key findings showed that certain modified compounds exhibited significant therapeutic activities with reduced side effects. The results support the potential of pyrazole derivatives as effective and safer options for pain and inflammation management. [ABSTRACT FROM AUTHOR]

As a hybrid weapon, two novel series of pyrazoles, 16a‐f and 17a‐f, targeting both COX‐2 and ACE‐1‐N‐domain, were created and their anti‐inflammatory, anti‐hypertensive, and anti‐fibrotic properties were evaluated. In vitro, 17b and 17f showed COX‐2 selectivity (SI = 534.22 and 491.90, respectively) compared to celecoxib (SI = 326.66) and NF‐κB (IC50 1.87 and 2.03 μM, respectively). 17b (IC50 0.078 μM) and 17 f (IC50 0.094 μM) inhibited ACE‐1 comparable to perindopril (PER) (IC50 0.048 μM). In vivo, 17b decreased systolic blood pressure by 18.6%, 17b and 17f increased serum NO levels by 345.8%, and 183.2%, respectively, increased eNOS expression by 0.97 and 0.52 folds, respectively and reduced NF‐κB‐p65 and P38‐MAPK expression by −0.62, −0.22, −0.53, and −0.24 folds, respectively compared to l‐NAME (−0.34, −0.45 folds decline in NF‐κB‐p65 and P38‐MAPK, respectively). 17b reduced ANG‐II expression which significantly reversed the cardiac histological changes induced by L‐NAME. [ABSTRACT FROM AUTHOR]

Objective: A novel triazolyl benzene sulfonamides were synthesized and evaluated for antitubercular and anticancer activity. Methods: Our study is dedicated to preparing highly efficient diphenyl pyrazole triazolyl benzene sulphonamides, as part of our ongoing efforts in the development of effective antitubercular and anticancer agents. The antitubercular activity was performed against the M. tuberculosis H37RV strain using a Microplate Alamar Blue Assay (MABA). The in silico pharmacokinetic profile (ADMET) and molecular docking studies were conducted using the enzyme crystal structure of Burkholderia cenocepacia dihydropteroate synthase complexed with 7,8-dihydropteroate (PDBID:2Y5S) and DHFR from Bacillus stearothermophilus (PDB ID: 1ZDR). Results and Discussion: The synthesis of eighteen novel derivatives was followed by the characterization, antitubercular, and anticancer screening of those compounds. Physical (MP and TLC) and spectral (FT-IR, 1H NMR, and MS) approaches were used to characterize the compounds. The H37RV strain was tested for antitubercular activity using the Microplate Alamar Blue Assay (MABA) method. When tested for antitubercular activity, compounds (Va), (Ve), and (VIIe) showed substantial activity at 50 µg/mL concentrations, whereas other substances showed action at 100 µg/mL concentrations. The compounds (Va), (Ve), and (VIIe) exhibit promising binding scores with DHTP and DHFR, which contributes to their efficacy as anticancer agents. The ADMET results have a positive impact on the effectiveness of the compounds. The same compounds have also demonstrated good results in the MTT assay ranging between 2 to 10 µg/mL, out of which (Va) showed strong cytotoxic activity of 1.73 µg/mL. Conclusions: The compounds were synthesized in quantitative yields and possessed antitubercular activity and anticancer activity. [ABSTRACT FROM AUTHOR]

Objective: A new series of pyrazole-3-carbaldehyde derivatives from new hydrazones by using the Vilsmeier–Haack reaction were synthesized. Pyrazoles have the characteristic qualities of the aromatic system, which are generally quite evident in their structures having insecticide, herbicide, and healthful significance as anti-inflammatory properties and antipyretic medication actions. Pyrazole compounds have a wide spectrum of bioactivity as reported in the literature, which encourages synthesis and testing of the antimicrobial activity for synthesis compounds. Methods: P-acetamido-phenol, and 2-mercaptobenzoimidazole, which used as a starting materials for synthesis pyrazole-3-carbaldehyde derivatives. The biological activity of some prepared compounds was also tested against two G-positive bacteria and two G-negative bacteria, in addition to C. albinos fungi. A molecular modeling study of some prepared compounds showed good binding strength with the target protein. Results and Discussion: Compound N-(4-((5-(4′-(4-formyl-1-phenyl-1H-pyrazole-3-carbonyl)-[1,1′-biphenyl]4-yl)-1,3,4-oxadiazol-2-yl)methoxy) phenyl)acetamide passes a good activity against Staphylococcus aurous; the compound 3-(4′-(5-(((1H-benzo[d]imidazol-2-yl)thio)methyl)-1,3,4-oxadiazol-2-yl)-[1,1′-biphenyl]-4-carbonyl)1-phenyl-1H-pyrazole-4-carbaldehyde passes good active with C. albinos. Molecular modeling was studied for the compounds prepared with human corona virus NL63, compound N-(4-((5-(4′-(4-formyl-1-phenyl-1H-pyrazole-3carbonyl)-[1,1′-biphenyl]-4-yl)-1,3,4-oxadiazol-2-yl)methoxy)phenyl)acetamide has best docking score –181.9 kcal/mol, while compound 3-(4′-(5-(((1H-benzo[d]imidazol-2-yl)thio)methyl)-1,3,4-oxadiazol-2-yl)[1,1′-biphenyl]-4-carbonyl)-1-(4-nitroph enyl)-1H-pyrazole-4-carbaldehyde has best hydrogen-bonding with –10 kcal/mol. In general, the binding by hydrogen bonding and steric interference was high, which leads to the conclusion that the prepared compounds have an effect on the Corona virus. Conclusions: The prepared compounds have biological activity and have good binding force with the Corona virus protein NL63, thus disrupting its work, and ccording to the toxicity assessment, the synthesized compounds belong to the third class (III). [ABSTRACT FROM AUTHOR]

Two new zinc azole complexes incorporated Strandberg-type cluster-based solids, namely (Hpz)6{Zn(pz)4(H2O)2}[{Zn(pz)2P2Mo5O23}2]·8H2O (1) and (Himi)4{Zn(imi)3P2Mo5O23}·7H2O (2) were crystallized using isomeric azole ligands, i.e., pyrazole (pz) and imidazole (imi), respectively. While solid 1 crystallized in triclinic system with space group P-1 with cell parameters a = 9.5647(15), b = 12.558(2), c = 20.340(3) Å, α = 75.907(7), β = 84.727(6), γ = 87.525(7)°, Z = 1; 2 crystallized in orthorhombic system with space group P212121 having cell parameters a = 12.048(3), b = 19.561(5), c = 20.732(5) Å, Z = 4. Both pyrazole and imidazole can form a complex with zinc centres to form an extended solid in 1 and a derivatized Strandberg-type cluster in 2. Interestingly, 1 is a new supramolecular isomer of previously reported solid viz., (pz)[{Zn(pz)3}3{P2Mo5O23}]·2H2O and 2 is the only example wherein a zinc imidazole complex has derivatized a Strandberg-type cluster. Detailed structure analysis of 1 and 2 was carried out, and the role of tectons in dictating the self-assembly of these solids was evaluated. In addition, a solid-state photoluminescence study was carried out for 1 and 2 at room temperature. Two zinc azole complexes incorporated Strandberg-type cluster-based solids and have been crystallized. While 1 is a new supramolecular isomer of (pz)[{Zn(pz)3}3{P2Mo5O23}]·2H2O; 2 is the only example wherein a zinc imidazole complex has derivatized a Strandberg-type cluster. Apart from detailed structural analysis, solid-state photoluminescence of solids has also been investigated. [ABSTRACT FROM AUTHOR]

Various types of materials have been explored in the pursuit of high energy density materials (HEDMs) that have balanced energy and stability. Among them, energetic salts show numerous advantages, such as lower vapor pressures, high physical stabilities, and the opportunity for favorable tuning by careful selection of cations/anions. Nitrogen-rich bases are generally used as cations for energetic salt formation. While the synthesis of salts with larger cations lowers the sensitivity, smaller cations aid better energetic performance. A combination of both in the same ionic moieties might help in the formation of a superior explosive. In this work, a facile route for the synthesis of mixed dicationic energetic salts based on 1-((1H-tetrazol-5-yl)methyl)-3,5-dinitro-1H-pyrazol-4-ol (compound 1) has been explored by various combinations of bigger and smaller cations (compounds 4-10). All the synthesized energetic salts showed high positive heats of formation, energetic performance comparable to TATB, excellent stability towards impact and friction, and acceptable thermal stabilities. This improved technique will provide an additional option for fine-tuning the energetic properties of HEDMs and will facilitate in exploring the role of various cations in the overall performance of the energetic compounds. [ABSTRACT FROM AUTHOR]

An efficient one‐pot synthesis of 1H‐pyrazoles has been realized via cascade cyclocondensation of β‐nitroalkenes as C2 synthon with α‐diazoesters as C1N2 unit. The reaction proceeds via concomitant formation of two new (C−N & C−C) bonds in one stretch leading to ethyl‐5‐nitro‐4‐phenyl‐4,5‐dihydro‐3H‐pyrazole‐3‐carboxylate intermediate, which undergoes base mediated denitration enabling the formation of NH−pyrazoles. This protocol not only features easy operation, catalyst−free conditions, good to high yields, wide scope and late‐stage functionalization, but also opens up a new avenue for synthetically demanding and structurally non‐traditional pyrazoles. A combination of experimental and DFT studies provide evidence for the proposed mechanism. [ABSTRACT FROM AUTHOR]

BackgroundDisabling pansclerotic morphea (DPM) is a rare systemic inflammatory disorder, characterized by poor wound healing, fibrosis, cytopenias, hypogammaglobulinemia, and squamous-cell carcinoma. The cause is unknown, and mortality is high.MethodsWe evaluated four patients from three unrelated families with an autosomal dominant pattern of inheritance of DPM. Genomic sequencing independently identified three heterozygous variants in a specific region of the gene that encodes signal transducer and activator of transcription 4 (STAT4). Primary skin fibroblast and cell-line assays were used to define the functional nature of the genetic defect. We also assayed gene expression using single-cell RNA sequencing of peripheral-blood mononuclear cells to identify inflammatory pathways that may be affected in DPM and that may respond to therapy.ResultsGenome sequencing revealed three novel heterozygous missense gain-of-function variants in STAT4. In vitro, primary skin fibroblasts showed enhanced interleukin-6 secretion, with impaired wound healing, contraction of the collagen matrix, and matrix secretion. Inhibition of Janus kinase (JAK)-STAT signaling with ruxolitinib led to improvement in the hyperinflammatory fibroblast phenotype in vitro and resolution of inflammatory markers and clinical symptoms in treated patients, without adverse effects. Single-cell RNA sequencing revealed expression patterns consistent with an immunodysregulatory phenotype that were appropriately modified through JAK inhibition.ConclusionsGain-of-function variants in STAT4 caused DPM in the families that we studied. The JAK inhibitor ruxolitinib attenuated the dermatologic and inflammatory phenotype in vitro and in the affected family members. (Funded by the American Academy of Allergy, Asthma, and Immunology Foundation and others.).

IntroductionAlopecia areata is a heterogenous, immune-mediated hair loss disorder that can affect any hair-bearing site on the body. Despite being one of the most prevalent autoimmune skin diseases, treatments have historically been limited to off-label medications that have demonstrated limited efficacy, especially in more severe forms of disease. Thus, there has long been an unmet need for rigorously studied therapeutics in alopecia areata.Areas coveredJanus kinase inhibitors have proven to be an effective class of drugs for treating several inflammatory disorders. One such drug, baricitinib, has recently demonstrated significant hair regrowth in phase 2 and 3 alopecia areata trials. It has since become the first systemic therapy approved for treating severe alopecia areata. This review examines the role of Janus kinase pathways in alopecia areata's pathogenesis and the safety and efficacy of baricitinib for treating severe alopecia areata.Expert opinionThe approval of baricitinib for treating severe alopecia areata marks a major milestone in the disease's history. While baricitinib has proven to be efficacious for this indication and has demonstrated an overall good safety profile, patients' individual risk factors for serious adverse events should be assessed during shared decision-making with patients before initiating treatment.

3,3‘,5,5‘-Tetranitro-4,4‘-bipyrazole monohydrate (TNBPz, 1⋅H2O) is an excellent precursor for the synthesis of new energetic materials (2–12). Several nitrogen-rich salts (e.g. guanidinium, aminoguanidinium, hydrazinium, ammonium and hydroxylammonium) were prepared from 1⋅H2O by neutralization reactions. In addition, the N-methylation and N-amination of compound TNBPz was investigated and is reported. All new synthesized energetic materials were fully characterized by NMR (1H, 13C, 14N, and 15N) spectroscopy, infrared spectroscopy, differential thermal analysis (DTA) and elemental analysis. Compounds 2, 4–8 and 10 were characterized with single crystal X-ray diffraction. The heats of formation for compounds 2, 4–6, 8, 11 and 12 were calculated using the atomization method based on CBS-4 M enthalpies. Several detonation parameters, such as detonation pressure, velocity and energy, were calculated by using the X-ray densities and the calculated standard molar enthalpies of formation. The sensitivities of all energetic materials toward external stimuli were tested according to the BAM standards. In addition, the toxicity toward vibrio fischeri bacteria of few energetic salts (3 and 4) is reported.

New series of thiazolyl-pyrazoline derivatives (7a-7d, 10a-10d and 13a-13f) have been synthesised and assessed for their potential EGFR and VEGFR-2 inhibitory activities. Compounds 10b and 10d exerted potent and selective inhibitory activity towards the two receptor tyrosine kinases; EGFR (IC50 = 40.7 ± 1.0 and 32.5 ± 2.2 nM, respectively) and VEGFR-2 (IC50 = 78.4 ± 1.5 and 43.0 ± 2.4 nM, respectively). The best anti-proliferative activity for the examined thiazolyl-pyrazolines was observed against the non-small lung cancer cells (NSCLC). Compounds 10b and 10d displayed pronounced efficacy against A549 (IC50 = 4.2 and 2.9 µM, respectively) and H441 cell lines (IC50 = 4.8 and 3.8 µM, respectively). Moreover, our results indicated that 10b and 10d were much more effective towards EGFR-mutated NSCLC cell lines (NCI-H1650 and NCI-H1975 cells) than gefitinib. Finally, compounds 10b and 10d induce G2/M cell cycle arrest and apoptosis and inhibit migration in A549 cancerous cells.

A new mode of reactivity of N‐sulfonylhydrazones towards alkynes is described: ketone‐derived N‐tosylhydrazones (NTHs) bearing α‐H atoms behave as [NN] synthons in their reactions with alkoxy alkynyl Fischer carbene complexes (FCCs) and only the two N atoms are incorporated into the newly formed pyrazole ring. The scope of the reaction, leading to 5‐methoxy‐N‐alkenyl pyrazoles, proved to be wide regarding both partners; thus, a variety of aryl and primary, secondary, and tertiary alkyl substituents are tolerated within the FCC, while aryl alkyl NTHs, symmetric and asymmetric dialkyl NTHs and NTHs derived of cyclic ketones can be also employed. In addition, the reaction can be performed at large scale and applied for late‐stage diversification of natural products. A reasonable reaction mechanism is also proposed, which is supported by deuteration experiments and DFT calculations. [ABSTRACT FROM AUTHOR]

The increase in multi-drug resistant Candida strains has caused a sharp rise in life-threatening fungal infections in immunosuppressed patients, including those with SARS-CoV-2. Novel antifungal drugs are needed to combat multi-drug-resistant yeasts. This study aimed to synthesize a new series of 2-oxazolines and evaluate the ligands in vitro for the inhibition of six Candida species and in silico for affinity to the CYP51 enzymes (obtained with molecular modeling and protein homology) of the same species. The 5-(1,3-diphenyl-1H-pyrazol-4-yl)-4-tosyl-4,5-dihydrooxazoles 6a-j were synthesized using the Van Leusen reaction between 1,3-diphenyl-4-formylpyrazoles 4a-j and TosMIC 5 in the presence of K2CO3 or KOH without heating, resulting in short reaction times, high compound purity, and high yields. The docking studies revealed good affinity for the active site of the CYP51 enzymes of the Candida species in the following order: 6a-j > 4a-j > fluconazole (the reference drug). The in vitro testing of the compounds against the Candida species showed lower MIC values for 6a-j than 4a-j, and for 4a-j than fluconazole, thus correlating well with the in silico findings. According to growth rescue assays, 6a-j and 4a-j (like fluconazole) inhibit ergosterol synthesis. The in silico toxicity assessment evidenced the safety of compounds 6a-j, which merit further research as possible antifungal drugs. [ABSTRACT FROM AUTHOR]

This article explores the use of pyrazolopyridine ligands in transition-metal-catalyzed reactions. These ligands have a wide range of effects and have been used in various oxidative and reductive reactions, as well as in applications such as solar cells and organic light-emitting diodes. The article discusses the synthesis of these ligands and their role in facilitating the formation of C-C and C-heteroatom bonds. It also provides specific examples of their use in different catalytic reactions, highlighting the importance of ligand design. The article encourages further research into the potential of pyrazolopyridine ligands in catalytic processes. [Extracted from the article]

This study depicts the synthesis of a novel biocatalyst Cluster Fig Ash (CFA) from cluster fig. XRD, FT‐IR, EDX, TGA, BET and SEM techniques were used to characterize the synthesized CFA catalyst. The one‐pot multicomponent synthesis of pyrano[2,3‐c]pyrazoles derivatives under ambient conditions was utilised to test the catalytic activity of this synthesized CFA biocatalyst. It was found that an easy, reliable, and extremely efficient method has been proposed to synthesise pyrano[2,3‐c]pyrazoles derivatives using one‐pot, multicomponent reaction involving aldehyde, malononitrile, ethylacetoacetate, and Hydrazine monohydrate. [ABSTRACT FROM AUTHOR]

New derivatives of 3-R-5-chloromethyl-1-thiocarbamoylpyrazole have been synthesized by the intramolecular heterocyclization of thiosemicarbazones of unsaturated ketones, obtained by the interaction of 3,4-dichlorobut-2-ene-1-ones with thiosemicarbazide, in a dioxane with a twofold excess of pyridine. The biological activity of a series of the synthesized substances in vitro has been studied and it has been revealed that the synthesized functional derivatives of pyrazoles show more expressed antimicrobial properties in relation to Staphylococcus aureus, Bacillus cereus, Escherichia coli and Candida albicans. [ABSTRACT FROM AUTHOR]

The behavior of N-Substituted 3,5-dimethyl-4-nitroso-1H-pyrazoles in oxidation, condensation, and reduction reactions was studied. The synthesized 4-aminopyrazole was acylated and diazotized with further azo coupling or the replacement of the amino group by iodine, as well as subjected to condensation with 4-nitrobenzaldehyde. The first condensation of nitrosopyrazole with 2,4-dinitrotoluene was demonstrated. As a result, new functionalized pyrazole derivatives were isolated. The structure of the novel pyrazoles was confirmed by IR and 1H and 13C NMR spectroscopy, gas chromatography-mass spectrometry, and elemental analysis. The synthesized compounds hold promise for further research in medicine and pharmaceutical chemistry. [ABSTRACT FROM AUTHOR]

Among a large number of nitrogen-containing heterocyclic compounds, pyrazole is a privileged scaffold with the molecular formula C3H3N2H. It consists of a five-membered ring with 3-carbon atoms and 2-nitrogen atoms which are present in adjacent positions. The nucleus has attracted synthetic interest due to numerous pharmacological activities. This molecule is used as one of the basic moieties for leads in the area of drug discovery and development and thereby plays a vital role in the field of medicinal chemistry. The present review article highlights the SAR studies of potent compounds of pyrazole and its derivatives (2015–2022) reported as anti-inflammatory, anticancer, antidiabetic, anticonvulsant, antimicrobial, antimycobacterial, antineurodegenerative and antioxidant. Furthermore, a patent application published in this period is also discussed. Google, PubMed, Cochrane, Scopus, ResearchGate, Google Scholar, and Science Direct were primarily used for article search, whereas the databases used for the pyrazole patent were Espacenet, Google Patent, and SciFinder. More than one hundred thirty papers were screened after which inclusion and exclusion criteria were applied to make this review article. We hope the current review article can pave the way for the future drug design and development of pyrazole derivatives as a potential drug candidate. [ABSTRACT FROM AUTHOR]

Aminopyrazoles represent interesting structures in medicinal chemistry, and several derivatives showed biological activity in different therapeutic areas. Previously reported 5-aminopyrazolyl acylhydrazones and amides showed relevant antioxidant and anti-inflammatory activities. To further extend the structure–activity relationships in this class of derivatives, a novel series of pyrazolyl acylhydrazones and amides was designed and prepared through a divergent approach. The novel compounds shared the phenylamino pyrazole nucleus that was differently decorated at positions 1, 3, and 4. The antiproliferative, antiaggregating, and antioxidant properties of the obtained derivatives 10–22 were evaluated in in vitro assays. Derivative 11a showed relevant antitumor properties against selected tumor cell lines (namely, HeLa, MCF7, SKOV3, and SKMEL28) with micromolar IC50 values. In the platelet assay, selected pyrazoles showed higher antioxidant and ROS formation inhibition activity than the reference drugs acetylsalicylic acid and N-acetylcysteine. Furthermore, in vitro radical scavenging screening confirmed the good antioxidant properties of acylhydrazone molecules. Overall, the collected data allowed us to extend the structure–activity relationships of the previously reported compounds and confirmed the pharmaceutical attractiveness of this class of aminopyrazole derivatives. [ABSTRACT FROM AUTHOR]

Poly‐stoichiometry of hydrated phases is relatively uncommon for organic materials and extended libraries of such species adopting different aqua‐to‐substrate ratios are still rare. The kinetically controlled higher hydrates could be particularly interesting for their structural relationships, which presumably may imprint some features of the substrate/substrate and aqua/substrate bonding in solutions, and provide insights into the nucleation stage. Two metastable high hydrates are prepared by crash crystallization. The crystal structures of 3,3′,5,5′‐tetranitro‐4,4′‐bipyrazole tetrahydrate, C6H2N8O8·4H2O, (1), and 3,3′,5,5′‐tetranitro‐4,4′‐bipyrazole pentahydrate, C6H2N8O8·5H2O, (2), are intrinsically related to the previously reported anhydrate and monohydrate, while displaying natural evolution of the patterns upon progressive watering. The accumulation of the water molecules causes their clustering, with the generation of one‐dimensional tapes and two‐dimensional layers in the genuine channel hydrates (1) and (2), respectively, versus the pocket hydrate structure of C6H2N8O8·H2O. The hydration primarily affects the pyrazole sites. It conditions the emergence of N—H...O and O—H...N hydrogen bonds, which is a destructive factor for pyrazole/pyrazole N—H...N hydrogen bonding. At the same time, extensive noncovalent interactions of the organic molecules, namely, lone pair–π‐hole O...N interactions of the NO2/NO2 and NO2/pyrazole types, are more competitive to the hydrogen bonding and the motifs of mutual organic/organic stacks remain intact with the increase in hydration. These trends agree with the results of Hirshfeld surface analysis. The contributions of the contacts involving H atoms are increased in line with the growing number of water molecules, while the fraction of O...N/N...O (NO2) contacts is nearly invariant. One may postulate the significance of the lone pair–π‐hole interactions to the aggregation of nitro species in solutions and their relevance for the sebsequent development of the solid‐state patterns through nucleation. [ABSTRACT FROM AUTHOR]

Five pyrazagalloles bearing H and CH3 substituents on the gallium atom and/or in the pyrazole ring have been calculated. The theoretical results have been compared with literature results concerning geometries from the Cambridge Data Base with very good agreement. 1H and 13C NMR results from the literature, scarce, and unpublished from our group are also well reproduced from GIAO calculations. The most important conclusion from this work is the assignment to a pz3Ga3 trimer as the isomer present in the 1H NMR spectra of dimeric pyrazagalloles. A mechanism connecting dimers and trimers has been found and the transition states identified. [ABSTRACT FROM AUTHOR]

A series of N-heterocyclic analogs of muricadienin, a precursor of various acetogenins, were synthesized, and their biological activity was studied. It was revealed that the linking group between the N-methylpyrazole/imidazole part and the hydrophobic alkadienyl chain affects the ability of these compounds to induce apoptosis and cause cell cycle arrest. Compound 3b showed the highest cytotoxic activity. [ABSTRACT FROM AUTHOR]

A safe and efficient method for the in‐situ preparation of (diazomethyl)dimethylphosphine oxide – a hereto unexplored diazoalkane reagent – is developed. The method is based on the diazotization of the corresponding P(O)Me2‐substituted amine (readily available in multigram quantities) in non‐aqueous media. The protocol provides the target product as ca. 1.5 M CHCl3 solution which is stable at −18 °C. The utility of the synthesized diazoalkane is illustrated by its [3+2] cycloaddition with electron‐poor alkynes and alkenes providing the corresponding P(O)Me2‐substituted pyrazoles and pyrazolines with moderate to good efficiency. In this view, the title compound represents and an important extension of medicinally relevant phosphine oxide reagents. [ABSTRACT FROM AUTHOR]

The nature of π-hole spodium bonds in the HgLCl2⋯ZH3/CH2Y complexes (L = pyrrole 1, pyrazole 2, imidazole 3, pyridine 4, pyridazine 5, and pyrimidine 6; Z = N, P, As, and Sb; Y = O, S, Se, and Te) has been studied using theoretical calculations. The electrophilicity of the π-hole in the tri-coordinated HgII complexes varies with the type of N-heterocyclic ligand. The strength and nature of the π-hole spodium bond is closely related to the properties of the Lewis bases. In the case of HgLCl2⋯ZH3, the strength of the π-hole spodium bond weakens as the nucleophilicity of the base decreases, following the sequence HgLCl2⋯NH3 > HgLCl2⋯PH3 > HgLCl2⋯AsH3 > HgLCl2⋯SbH3. The Hg⋯Z spodium bonds change from a partially covalent interaction to a close-shelled noncovalent interaction. The nucleophilic ability of CH2Y decreases in the order CH2O > CH2S > CH2Se > CH2Te, while the strength of the π-hole spodium bond follows the order HgLCl2⋯OCH2 < HgLCl2⋯SCH2 < HgLCl2⋯SeCH2 < HgLCl2⋯TeCH2. The Hg⋯Y spodium bond undergoes a transition from a close-shelled noncovalent to a partially covalent interaction, resulting in an incremental increase in the degree of covalence. The Hg⋯Te spodium bond exhibits certain characteristics resembling those of a coordinate covalent bond. The inter-orbital interactions observed in the formation of the HgLCl2⋯YCH2 complexes appear to be significantly stronger compared to those observed in the HgLCl2⋯ZH3 complexation. [ABSTRACT FROM AUTHOR]

Herein, a general and practical temperature-controlled approach for the divergent synthesis of pyrazoles and 1-tosyl-1H-pyrazoles via electrophilic cyclization in the absence of transition-metal catalysts and oxidants was developed. The desired products were obtained in moderate to excellent yields from common starting materials in both ionic liquids and ethanol by simply tuning the reaction temperature. This strategy employs easily synthesized substrates, mild reaction conditions, and excellent functional-group tolerance. [ABSTRACT FROM AUTHOR]

Synthesis of primary lanthanide amides in the bis‐hydrotris(1‐pyrazolyl)borate ligand environment has been achieved. Salt metathesis of [Dy(Tp)2(OTf)] 1‐Dy (OTf=CF3SO3) with K(N′′) (N′′=N(SiMe3)2) in toluene yielded the [bis(silyl)]amide [Dy(Tp)2(N′′)] 2‐Dy. Complexes 1‐Ln and 2‐Ln were both used to access primary lanthanide amides, where either metathesis of 1‐Ln with K(NHArCF3) (ArCF3=C6H3(CF3)2‐3,5) or protonolysis of 2‐Ln with H2NArCF3 in toluene yielded [Ln(Tp)2(NHArCF3)] 3‐Ln (Ln=Y, Dy). The synthesis of parent amides was also attempted, but the metathesis of 1‐Y with NaNH2 yielded complicated reaction mixtures, but from which the dimeric parent amide [{Y(Tp)2(μ‐NH2)}2] 4‐Y and an 'ate'‐salt [{Y(Tp)2(μ2‐OTf)(μ3‐OTf)Na(THF)2}2] 5‐Y were isolated. Full characterisation data are presented for all complexes, including the structure determination. [ABSTRACT FROM AUTHOR]

Natural products have been extensively explored for their role in drug design and development to eradicate numerous types of diseases. Also, heterocycles‐based motifs are known to possess a wide range of therapeutic applications. Among them, pyrazole is a well‐exploited scaffold by researchers in the different fields of medicinal chemistry. Recently, pharmacophoric hybridization became most urged approach in which two biologically active pharmacophoric skeletons tend to fuse together in any structural portion. Hence, pyrazole and its cyclic bio‐isosteres may clubbed together to design and develop novel potent molecules against clinical disorders with least toxicity profile. In the present review, we aim to compile the numerous recent advancements in the medicinal chemistry of natural metabolites containing pyrazole and its bio‐isosteres hybrid compounds with the following objectives: (1) To summarize the recent literature reports of last six years that are focused on the biological potential of natural pyrazole and its bio‐isosteres hybrid derivatives; (2) To deliberate current developments in the medicinal aspect of natural compounds through their structural alteration by introducing pyrazole and its cyclic analogues; (3) To emphasize the complete correlation between structure activity relationship (SAR) and therapeutic response to disclose productive concepts for the generation of potential semi‐synthetic candidates. [ABSTRACT FROM AUTHOR]

In search of novel antimicrobial agents, new series of N-(arylsulfonyl)-l-proline-derived hybrids tethered with pharmacologically attractive cores as 1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazine and 5-(Piperazin-1-yl)benzofuran-2-carboxamide were synthesized and evaluated for in vitro antimicrobial potential against six different representative human pathogenic strains. Among all, N-acetyl derivative 5e containing phenylpyrazolyl moiety displayed an appreciable inhibitory value (MIC: 107 µg/mL) with noteworthy binding energy (–6.65 kcal/mol) against S. aureus as compared to standard ampicillin (MIC: 250 µg/mL). The N-phenyl-pyrazolyl containing analogue 5b elicited comparable activity against E. coli and P. aeruginosa with MIC values of 104 µg/mL and 121 µg/mL, respectively. Moreover, 5b, 5d, and 6c showed appreciable antioxidant activity (IC50:19.25–20.69 µg/mL) as compared to butylated hydroxytoluene (BHT, IC50:16.47 μg/mL). Molecular docking studies against target tyrosyl-tRNA synthetase (TyrRS) of S. aureus (PDB: 1JIJ) revealed the potential binding mode of the ligands to the appropriate site of targets and their plausible mechanism of in vitro antibacterial activity. [ABSTRACT FROM AUTHOR]

In this study, pyrazole tartrate (Pya·DL) and tartaric acid (DL) complexed with cobalt–iron bimetallic modified hydrogen-type mordenite (HMOR) were prepared using the ion exchange method. The results demonstrate that the stability of the dimethyl ether (DME) carbonylation reaction to methyl acetate (MA) was significantly improved after the introduction of Pya·DL to HMOR. The Co∙Fe∙DL-Pya·DL-HMOR (0.8) sample exhibited sustainable stability within 400 h DME carbonylation, exhibiting a DME conversion rate of about 70% and MA selectivity of above 99%. Through modification with the DL-complexed cobalt–iron bimetal, the dispersion of cobalt–iron was greatly enhanced, leading to the formation of new metal Lewis acidic sites (LAS) and thus a significant improvement in catalysis activity. Pya·DL effectively eliminated non-framework aluminum in HMOR, enlarged its pore size, and created channels for carbon deposition diffusion, thereby preventing carbon accumulation and pore blockage. Additionally, Pya·DL shielded the Bronsted acid sites (BAS) in the 12 MR channel, effectively suppressing the side reactions of carbon deposition and reducing the formation of hard carbon deposits. These improvements collectively contribute to the enhanced stability of the DME carbonylation reaction. [ABSTRACT FROM AUTHOR]

A theoretical study of the formation of carbamic acids of pyrazole and indazole has been carried out using DFT computational methods. The effects of the substituents and the solvent (using explicit and implicit solvent models) have been considered. In addition, the deprotonation of the carbamic acid and its influence on the stability of the system has been calculated. In the neutral systems, only the formation of indazole-1-carbamic acid derivatives is favored vs. the non-covalent complexes between pyrazole or indazole with CO2. The deprotonation of the carbamic acid highly stabilizes the system preventing its dissociation. [ABSTRACT FROM AUTHOR]